What is DCTH's P/E ratio?

Delcath Systems Inc (DCTH) currently trades at a P/E ratio of 117.85.

Delcath Systems Inc reports a Return on Equity (ROE) of 0.50%.

What is DCTH's dividend yield?

Delcath Systems Inc offers a dividend yield of 0.00%.

What is DCTH's Quality Score?

Our AI rates DCTH's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy DCTH?

Our AI Timing Score for DCTH is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does DCTH belong to?

Delcath Systems Inc is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

Delcath Systems Inc (DCTH) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

DCTH AI Analysis Summary

Our AI summary for DCTH: Delcath Systems Inc (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 117.85, ROE of 0.50%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 70/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

DCTH

Delcath Systems Inc

US:NASDAQ STOCK Healthcare >> Medical Devices News 84

USD 12.22

0.18 (1.50%) Day Change

Watchlist Portfolio Compare Chart

117.85

P/E

0.00

D/E

0.5%

ROE

0.5%

ROA

0.00%

Div Yield

-1.73

PEG

DELCATH SYSTEMS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 12.22 Price 0.18 (1.50%) Day Change	NEWS SCORE: 84

DCTH, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	84
Magic Formula Rank by ROA	2879
Magic Formula Rank by ROE	2879
Magic Formula Rank by ROIC	1613
Price	12.22
PBV / Sector	3.69 / -101.57
Earning Per Share	0.02

PE / Sector	117.85 / 31.23
PEG or PE/Growth / Sector	-1.73 / 0.40
Average 1M Daily Value	4.34 M GREAT
Average 1W Daily Value	4.64 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	0.62 / 20.50
NPM Average (%) / Sector	-743.74 / -15.37
NPM Change Average (%) / Sector	-52.46 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	0.45 / 39.11
ROA Average (%) / Sector	-71.94 / 5.58
ROA Change Average (%) / Sector	-74.36 / 104.50
ROE (%) / Sector	0.50 / -166.42
ROE Average (%) / Sector	57.09 / -16.93 GREAT
ROE Change Average (%) / Sector	-105.40 / -500.08
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 07:59:42
Symbol	DCTH
Name	DELCATH SYSTEMS INC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	34.52 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	415.64 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 566 Queensbury Avenue, Queensbury, NY, United States, 12804

Phone: 212 489 2100

Website: https://www.delcath.com

Employees: 156

Sector: Healthcare >> Medical Devices

Description: Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.